Blog

In a significant advancement for cancer research and treatment, researchers at Cedars-Sinai Health Sciences University have developed an innovative AI tool that promises to make gene expression...

In a significant advancement for cancer research and patient care, a team from Cedars-Sinai Health Sciences University has unveiled a new artificial intelligence (AI) tool designed to make gene...

In a recent study, researchers have uncovered critical insights into why some cancer cells behave aggressively, proliferating rapidly and spreading throughout the body. This discovery sheds light on...

In a significant breakthrough for oncology, recent research has shed light on why certain cancer cells exhibit aggressive behavior, making them resilient to treatment and capable of spreading...

In a significant development for prostate cancer treatment, recent research has established a connection between PSMA-PET imaging and advanced treatment options for patients with metastatic prostate...

Recent advancements in medical imaging are paving the way for more precise and effective treatments for prostate cancer. The latest research, as highlighted by a recent article from Newswise, has...

The recent announcement of promising results from a phase 1/2 clinical trial of daraxonrasib, a targeted RAS inhibitor, marks a significant step forward in the treatment of metastatic pancreatic...

Recent research has shed light on a significant link between gut bacteria and colorectal cancer, underscoring the importance of understanding microbial influences on health. A study published by...

In a significant push for progress in cancer treatment, the Association of American Cancer Institutes (AACI) has urged Congress to pass the Clinical Trial Modernization Act (S. 4440). This bipartisan...

In a significant move for cancer research and patient care, the Association of American Cancer Institutes (AACI) is urging Congress to pass the Clinical Trial Modernization Act (S. 4440). This...

Recent research from Johns Hopkins University has unveiled a compelling link between inherited long telomeres and an increased risk of lymphoid cancers, such as lymphoma. This discovery not only...

Recent findings from researchers at the Johns Hopkins Kimmel Cancer Center highlight a crucial genetic condition linked to unusually long telomeres, which could significantly impact cancer risk and...

In a significant advancement for pancreatic cancer treatment, researchers have reported promising results from a phase 1/2 clinical trial of daraxonrasib, a targeted RAS inhibitor. Conducted by a...

The American Society of Clinical Oncology (ASCO) annual meeting is a significant event in the oncology calendar, serving as a platform for researchers to share their latest findings with the medical...

The recent announcement from The University of Texas MD Anderson Cancer Center about the promising results of daraxonrasib, a new oral RAS inhibitor, brings a glimmer of hope to patients battling...

In a significant development for pancreatic cancer treatment, researchers have unveiled promising results from the RAS inhibitor daraxonrasib, which targets specific mutations that drive this...

Recent developments in cancer research have illuminated a promising path toward earlier diagnosis and more effective treatment for one of the most aggressive forms of breast cancer: inflammatory...

Recent advancements in cancer research have the potential to change the way we approach some of the most aggressive forms of the disease. A groundbreaking study from scientists at The University of...

Recent advancements in medical technology are paving the way for innovative treatment options in the fight against cancer. A systematic review and meta-analysis recently published highlights the...

The recent announcement from The Wistar Institute regarding Dr. Dario C. Altieri’s upcoming transition from his role as president and CEO highlights a pivotal moment not only for the institute but...